$MNKD News 3 overlooked stocks loved by top-ranked

New Post Public Reply Private Reply Replies (0) Message Board

Jun 4, 2014 at 7:49 PM

$MNKD News

3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:15 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Sue Chang
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - Russ Britt
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - Russ Britt
Stock futures pare gains after ADP 8:59 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:14 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:14 a.m. April 2, 2014 - Barbara Kollmeyer
Apollo shares slip after revenue falls short 6:54 p.m. April 1, 2014 - Wallace Witkowski
7 gut checks before the stock market's opening bell 6:25 a.m. Aug. 15, 2013 - Shawn Langlois
On a mixed day, two biopharma firms' insulin drugs vie for investors 11:41 a.m. June 19, 2013 - Russ Britt
MannKind shares leap as web site says firm is a ripe takeover target 1:32 p.m. May 22, 2013 - Russ Britt
MannKind up 6.9% in premarket 8:43 a.m. Jan. 2, 2013 - Steve Gelsi
MannKind prices offering at 23% discount 10:04 a.m. Oct. 18, 2012 - MarketWatch.com
MannKind down 25% in premarket 8:59 a.m. Oct. 18, 2012 - Steve Gelsi

MannKind continues its bull run 12:16 p.m. Today - Seeking Alpha
MannKind (MNKD) Surges to 52-Week High as Afrezza Approval Approaches 11:58 a.m. Today - TheStreet.com
Hottest Healthcare Stocks Now – EXAS MNKD KERX MYGN 8:00 a.m. Today - InvestorPlace.com
As Predicted, MannKind Starting Emotionally Fueled Run To FDA Approval, When It May Be Best To Go Short 8:59 a.m. June 3, 2014 - Seeking Alpha
MannKind (MNKD) at Jefferies Global Healthcare Conference (Transcript) 7:25 p.m. June 2, 2014 - Seeking Alpha
MannKind's (MNKD) Management Presents at Jefferies Global Healthcare Conference (Transcript) 7:25 p.m. June 2, 2014 - Seeking Alpha
5 Stocks With Poor Sales Growth — HTS MITT LPCN MNKD UEC 10:00 a.m. June 2, 2014 - InvestorPlace.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD LCI RDY NBIX 7:45 a.m. May 30, 2014 - InvestorPlace.com
The Seven Deadly Sins of Biotech Investing 7:00 a.m. May 29, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – HZNP MNKD BSX ISIS 1:45 p.m. May 28, 2014 - InvestorPlace.com
Short MannKind On Afrezza Approval? 3:33 p.m. May 27, 2014 - Seeking Alpha
MannKind Annual Shareholder Meeting Provides Further Optimism For Afrezza And Technosphere Platform 3:05 p.m. May 27, 2014 - Seeking Alpha
One Small Step For Afrezza, One Huge Step For MannKind? 10:44 a.m. May 27, 2014 - benzinga.com
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog 9:22 a.m. May 21, 2014 - Zacks.com
Hottest Healthcare Stocks Now – CLVS CYH AZN MNKD 9:00 a.m. May 20, 2014 - InvestorPlace.com
MannKind: Approval For Afrezza Looking More And More Positive As Investors Await FDA Decision 10:03 a.m. May 19, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ICLR PRXL MNKD SGEN 6:15 a.m. May 19, 2014 - InvestorPlace.com
Twelve Analyst Stocks to Buy Under $10 for Big Upside 8:35 a.m. May 17, 2014 - 247WallSt.com

MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:01 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:01 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:00 a.m. April 17, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:01 a.m. April 15, 2014 - ACCESSWIRE
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF
FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, Steris, Retrophin, and NxStage Medical 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Petr Announces Well Online and Estimates 26,000 Barrels of Oil per Day; MannKind's Afressa Drug Decision Extended by the FDA 1:05 a.m. April 8, 2014 - ACCESSWIRE
MannKind Updates Status of New Drug Application for AFREZZA(R) 4:00 a.m. April 7, 2014 - GlobeNewswire
Pre-Market Review on Top Gainers -- Research on MannKind, ZBB Energy, B2Gold, and DFC Global 9:08 a.m. April 3, 2014 - PR Newswire - PRF
Insider Trading Alert - Free Research of General Motors, Apple, RF Micro Devices, MannKind, Sirius XM, and Plug Power 8:55 a.m. April 3, 2014 - PR Newswire - PRF
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 9:49 a.m. April 2, 2014 - ACCESSWIRE
FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation's Investigational Drug to Treat Diabetes 5:47 p.m. April 1, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

The Melt Expands with Key Texas Franchise Deal

Throwing Down the Gauntlet: The Melt Expands If there's one thing I've learned after decades watching these restaurant chains multiply like rabbits it’s this: when a veteran gets involved, you perk up. The Melt has done just that by roping in Syed Ahmad—a name that actually means something in this game—to open eight new locations in the Lone Star State. It isn't...

Nonprofit and Partners Gift Homes to Veterans

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

AI Deception Challenges the Confidence of Fraud Defenses

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Wiz Khalifa Ignites MJBizCon 2026 with Keynote and Music

An Icon in Cannabis Culture Hits the Stage When you mix business with pleasure, you get something like what MJBizCon's cooking up this year. Wiz Khalifa, the man with a knack for turning passion into profit, is jumping onto the stage—not just as a performer, but also as a keynote speaker. On December 2, attendees are in for a treat as he steps into a new spotlight at...

Choosing the Right Pressure-Treated Lumber for Projects

Diving into the World of Pressure-Treated Lumber John Michael Nixa, the go-to expert from West Side Lumber, has dropped some real nuggets in the world of pressure-treated lumber. This isn't some clickbait headline; it's about making sure your deck or fence doesn't fall apart after the first thunderstorm. Understanding the Lumber Treatment Now, before you run off to the...

Honoring Boston's Architects Changing the Game

Celebrating Architecture's Influencers in Boston Every now and then, a profession needs a wake-up call. Stirring the pot, shaking the roots, call it what you will, but when folks rally together with a shared vision, change doesn't just seem possible — it's inevitable. On November 12, the Boston Society of Architects (BSA) and Architecture in Common (AiC) did just that...

Pine AI Unveils AI Studio & Real-World Call Feature

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

HiTHIUM Joins Cambridge to Boost Global Energy Storage

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Anderson University Sees Financial Turnaround Success

Anderson University, against all odds, is shaking up the financial narrative they’ve been stuck in for a while. It’s kind of like finding a $20 bill in an old coat—a nice surprise but it doesn’t happen every day. The university’s recent report on their financial progress is reminding folks that when it comes to fiscal discipline, sometimes you just need fresh...

Fluence Energy Faces Class Action: Investor Insights

Investor Blues: Fluence Under the Weather If you've been keeping an eye on Fluence Energy (NASDAQ:FLNC), you're probably clutching your metaphorical pearls right now. Here's the scoop: on November 2, 2026, the stock took another nosedive—dropping nearly 9%—as the company announced that both CEO Julian Nebreda and CFO Ahmad Pasha had packed their bags. A leadership...